Hospice News June 24, 2020
Jim Parker

While private equity interest in the hospice space remains hot, some players have abandoned or postponed plans to bring their holdings to the acquisitions market during the COVID-19 pandemic. While many expect the market to rebound by the third or fourth quarter of the year, nothing is certain as COVID cases continue to spike throughout the United States.

A number of factors have whetted the appetites of private equity firms for hospice in recent years, including the fragmented nature of the industry, increased acceptance of palliative care services, demographic tailwinds, the changing regulatory landscape, and movement towards value-based payment models.

In the long term, these investors are unlikely to lose interest, though specific transactions may see further delays due to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Post-Acute Care, Provider, Trends
Health care waste exposed [PODCAST]
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Google DeepMind unveils ‘superhuman’ AI system that excels in fact-checking, saving costs and improving accuracy
Pelago Defies Digital Health Funding Drought, Raises $58M
Nation's 1st double lung-liver transplant performed at Northwestern

Share This Article